Experience on pharmaceutical care in a renal transplantion recipient with herpes zoster

JI Xiaoli; DAI Ying; SONG Hongtao

doi:10.3969/j.issn.1006-0111.2015.01.019

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To report experience on pharmaceutical care in a renal transplantation recipient with herpes zoster. Methods The methods and measures of pharmaceutical care of a renal transplantation recipient with herpes zoster were retrospectively summarized. Results A safety, effectiveness, rationality of medication were significantly increased by pharmaceutical care in renal transplantation patient's with herpes zoster and the patient's quality of life was improved. Conclusion Pharmaceutical care was necessary and valuable to renal transplantation recipients with herpes zoster.

Experience on pharmaceutical care in a renal transplantion recipient with herpes zoster

1. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

2. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China

Received Date: 2013-06-03

Rev Recd Date: 2013-11-11

Key words:

Abstract: Objective To report experience on pharmaceutical care in a renal transplantation recipient with herpes zoster. Methods The methods and measures of pharmaceutical care of a renal transplantation recipient with herpes zoster were retrospectively summarized. Results A safety, effectiveness, rationality of medication were significantly increased by pharmaceutical care in renal transplantation patient's with herpes zoster and the patient's quality of life was improved. Conclusion Pharmaceutical care was necessary and valuable to renal transplantation recipients with herpes zoster.

HTML

Reference (13)

[1]	Fehr T,BossartW,Wahl C,et al.Dissem inated varicella infection in adult renal allograft recipients: four cases and a review of the literature[J].Transplantation,2002,73(4):608-611.
[2]	Dellue A,Mocquard Y,Latour P,et al.Encephalopathy and acute renal failure during acyclovir treatment[J].Rev Neurol (Paris),2004,160 (6-7):704-706.
[3]	Glustina A,Romanelli G,Cimino A,et al. Low-dose acyclovir and acute renal failure[J].Ann Intem Med,1988,108(2):312.
[4]	Rostaing L,Izopet J,Sandres K,et al. Changes in hepatitis c virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil[J].Transplantation,2000, 69 (5) : 991-994.
[5]	Rothwell WS, Gloor JM, Morgenstern BZ, et al. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil[J].Transplantation,1999,68 (1): 158-161.
[6]	Yuan R,Zhang X,Deng Q,et al. Impact of CYP3A4*1G polymorphism on metabolism of fentanyl in Chinese patients undergonging lower abdominal surgery[J].Clin Chim Acta,2004,412(9):755-760.
[7]	Zbou M,Zhou D,He L.Postherpetie neuralgia in herpes zoster[J].JAMA,2009,302: 1862-1863.
[8]	周静.糖皮质激素在带状疱疹治疗中的应用[J].皮肤病与性病,2007,29(4):14-16.
[9]	高洁,崔桅,孟庆杰,等.环孢素与其他药物相互作用的研究进展[J].中国药业,2008,17(8):60-61.
[10]	孙培红,鲁云兰.质子泵抑制剂的代谢比较[J].中国医院用药评价与分析,2003,3(2):122-124.
[11]	Penfornis A,Kury-Paulin S.Immunosuppressive drug-induced diabetes[J].Diabetes Metab,2006,32(5 Pt 2): 539-546.
[12]	Nichelle L,Canet S,Garrigue V, et al. Arterial hypertention in renal transplant recipients treated with tacrolimus or cyclosporine-neoral[J].Transplant Proc,2002,34(7):2824-2825.
[13]	Ligtenberg G,Hen RJ,Blankestijn PJ,et al. Cardiovascular risk factors in renal transplant patients: cyclosporine A versus tacrolimus[J].J Am Soc Nephrol,2001,12(2):367-373.

Message Board

Experience on pharmaceutical care in a renal transplantion recipient with herpes zoster

doi: 10.3969/j.issn.1006-0111.2015.01.019

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views